Sight Sciences, Inc. (SGHT) Technical Analysis & Indicators

Sight Sciences, Inc. (SGHT) — Price $8.14 HealthcareMedical - Devices — NASDAQ

Latest reported results:

Technical analysis of Sight Sciences, Inc. (SGHT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.

Price Performance

1 month-0.97%
3 months+54.17%
Year-to-date+2.65%
1 year+138.01%
3 years+140.83%
5 years-68.18%

52-Week Range

52-week High$9.24
52-week Low$3.19
Avg Volume (90d)210K

Technical Indicators

SMA 50$6.92
SMA 200$5.87
Beta2.49
30-day Volatility (annualised)77.3%
Price vs SMA 50+17.6%
Price vs SMA 200+38.6%

Monthly Close (12 months)

MonthCloseChange
2025-10$5.06
2025-11$8.36+65.2%
2025-12$7.93-5.1%
2026-01$6.28-20.8%
2026-02$5.16-17.8%
2026-03$3.77-26.9%
2026-04$4.09+8.5%
2026-05$4.86+18.8%
2026-06$5.42+11.5%
2026-07$5.26-3.0%
2026-08$8.50+61.6%
2026-09$8.14-4.2%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-09-14$-2.53
2026-09-14$159M
2026-09-14$-0.26$14M
2026-09-14
2026-09-14$0.84$26M
2026-09-14

Price

Price$8.14
Market Cap$443M
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book8.43
EV / EBITDA-15.74
Dividend Yield0.00%

Financial Health

Debt / Equity0.79
Current Ratio4.95

Related companies: CERS · CVRX · LFCR · MASS · OMI · PRQR · QTRX

Explore sector: Healthcare · Medical - Devices

More sections of SGHT: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks